For decades, clinical trials have operated adjacent to care.

Patients leave their usual providers to travel to research centers. Sites operate parallel to routine clinical workflows. Documentation, oversight, and logistics often require separate systems and processes.

That separation has long been accepted as necessary for rigor.

But the model is straining.

As protocols grow more complex and access gaps persist — especially in rural and community settings — the next phase of trial delivery is emerging: embedding research directly into routine care pathways.

Not as an add-on. As infrastructure.

From Separate to Integrated

Traditional site-centric models concentrate research activity in academic medical centers. While these institutions offer deep expertise and established oversight structures, they also create structural access barriers. Travel burden, scheduling conflicts, and capacity constraints limit who can realistically participate.

Embedding research into existing care pathways shifts the equation.

Instead of asking patients to enter a separate ecosystem, the trial becomes part of their established care journey. Community health systems, regional hospitals, and trusted local providers participate under clearly defined supervisory frameworks. Investigational product logistics, lab workflows, and documentation processes are integrated into routine operations rather than layered on top.

This model expands reach without lowering standards.

Oversight Does Not Disappear — It Evolves

A common misconception is that embedding research into care dilutes oversight.

In practice, it requires more intentional governance.

When non-investigator healthcare providers support aspects of trial execution, responsibilities must be explicit. Tiered supervision models clarify which activities can occur locally and which require centralized review. Data flow must be structured and traceable. Chain-of-custody for investigational products must be documented rigorously.

The difference is not less oversight. It is distributed oversight, supported by centralized coordination.

Hub-and-spoke structures have proven particularly effective. Central teams manage regulatory submissions, quality assurance, biospecimen handling, and safety review. Local providers deliver care elements aligned with their existing workflows.

Clear boundaries maintain scientific integrity while expanding participation.

Designing for Real-World Delivery

Embedding research into care works best when protocol design reflects operational reality.

Highly complex eligibility criteria, redundant data collection, and frequent in-person visits may be manageable in academic centers with dedicated research staff. They are far more difficult to sustain in community environments.

When sponsors integrate epidemiological data, site intelligence, and operational feedback earlier in protocol development, they can identify delivery constraints before activation. Leaner schedules of activities, pragmatic endpoints, and realistic monitoring strategies improve both feasibility and scalability.

Trial delivery is not separate from trial design. It is shaped by it.

The Community Health System Opportunity

Community health systems represent one of the largest untapped opportunities in clinical research.

Patients often trust their local providers deeply. When research is offered within that familiar environment, participation becomes less intimidating and more convenient. Continuity of care is preserved. Travel burden decreases. Retention improves.

For health systems, embedding research creates new clinical pathways without requiring them to build standalone research departments. With centralized support for regulatory documentation, data management, and sponsor coordination, local clinicians can offer trial participation as an extension of care rather than a competing activity.

Research becomes part of the standard conversation.

Infrastructure Before Expansion

Expanding trial delivery into routine care requires infrastructure.

Standardized onboarding for local providers. Defined communication pathways. Digital systems that integrate rather than duplicate workflows. Clear compensation and contracting structures. Training that reflects real-world constraints.

Without these elements, embedding research risks overwhelming already stretched clinical teams.

With them, research becomes more sustainable.

The shift is not from academic centers to community settings. It is from concentration to coordination.

A More Inclusive Model

Embedding research into routine care also addresses long-standing representation gaps.

Rural communities, patients with limited transportation access, and individuals managing work or caregiving responsibilities often struggle to participate in traditional site-centric trials. When trials are integrated into care environments patients already visit, participation barriers decrease.

Access expands not because motivation changes, but because structure changes.

The next phase of trial delivery will be defined less by where research is located and more by how seamlessly it integrates into everyday care.

Embedding research into routine care does not compromise rigor. It strengthens reach.

Continue the Conversation at SCOPE Summit Europe

As clinical trial delivery models continue to evolve across regions and care systems, the integration of research into routine healthcare remains a critical focus.

Registration is now open for SCOPE Summit Europe, where leaders from sponsors, CROs, health systems, and research sites will explore how design, data, and delivery intersect across diverse global settings.

Learn more and register here.